30
Aug
2024
The murderer Case report
More Story
Esketamine nasal spray: New hope for resistant depression
August 2, 2024 - 7:56 PM
On March 05, 2019 The U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray, in conjunction... Recent Posts
- Amphetamine-Linked Priapism Risks
September 6, 2024 - 6:42 PM - The murderer Case report
August 30, 2024 - 10:33 AM - Esketamine nasal spray: New hope for resistant depression
August 2, 2024 - 7:56 PM - Buvidal : a new hope for opiate addiction?
August 2, 2024 - 6:09 PM - Normal Pressure Hydrocephalus:
July 13, 2024 - 12:18 PM - Dopamine receptors in the brain
June 7, 2024 - 1:53 PM - Lewy Body Dementia
June 6, 2024 - 12:16 PM
- Amphetamine-Linked Priapism Risks